Wedgewood Partners, an investment management company, released its fourth-quarter 2024 investor letter. A copy of the letter ...
TPL and TSM were top performers, while CDW and UnitedHealth were notable detractors for both the quarter and the year. Click ...
The transcatheter aortic valve implantation gives patients the opportunity to continue their daily lives with minimal ...
JJ is a 75-year-old man who presents to the office after his wife made an appointment for him this morning for evaluation of ...
New York, USA, Jan. 13, 2025 (GLOBE NEWSWIRE) -- Myocardial Infarction Clinical Trial Pipeline Appears Robust With 45+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight ...
[9] Warfarin reduced the risk of the primary end point among patients with basilar artery stenosis ... medical therapy has failed to alleviate symptoms. Prior to pursing an intervention, the ...
Background and aims Hypertrophic cardiomyopathy (HCM) has various aetiologies, including genetic conditions like Fabry ...
Large and rare duplications and deletions in a chromosome region known as 22q11.2 , which involves genes that regulate ...
Large and rare duplications and deletions in a chromosome region known as 22q11.2 , which involves genes that regulate ...
Doctors at Rainbow Children’s Heart Institute, Hyderabad, achieved a milestone by performing a fetal balloon aortic ...